Your browser doesn't support javascript.
loading
HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.
Culié, Dorian; Rousseau, Alexandra; Pretet, Jean-Luc; Lacau Saint Guily, Jean.
  • Culié D; Antoine Lacassagne Centre, University Institute of the Face and Neck, Côte d'Azur University, Nice, France. dorian.culie@nice.unicancer.fr.
  • Rousseau A; Department of Clinical Pharmacology and Clinical Research Unit of East of Paris (URC-Est), Assistance Publique-Hôpitaux de Paris (AP-HP), Saint Antoine Hospital, 75012, Paris, France.
  • Pretet JL; COMUE UBFC, Besançon University Hospital-Jean Minjoz, Franche-Comte University, 25030, Besançon Cedex, France.
  • Lacau Saint Guily J; Inserm CIC 1431, 25030, Besançon Cedex, France.
Eur Arch Otorhinolaryngol ; 279(6): 3071-3078, 2022 Jun.
Article en En | MEDLINE | ID: mdl-34661716

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas / Infecciones por Papillomavirus / Alphapapillomavirus Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Orofaríngeas / Infecciones por Papillomavirus / Alphapapillomavirus Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article